110 related articles for article (PubMed ID: 16372263)
21. The effect of vitamin C supplementation in healthy dogs on antioxidative capacity and immune parameters.
Hesta M; Ottermans C; Krammer-Lukas S; Zentek J; Hellweg P; Buyse J; Janssens GP
J Anim Physiol Anim Nutr (Berl); 2009 Feb; 93(1):26-34. PubMed ID: 19386005
[TBL] [Abstract][Full Text] [Related]
22. Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients.
Ono K
Clin Nephrol; 1986 Nov; 26(5):239-43. PubMed ID: 3802587
[TBL] [Abstract][Full Text] [Related]
23. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
Himmelfarb J; Phinney S; Ikizler TA; Kane J; McMonagle E; Miller G
J Ren Nutr; 2007 Sep; 17(5):296-304. PubMed ID: 17720098
[TBL] [Abstract][Full Text] [Related]
24. Life-long vitamin C supplementation in combination with cold exposure does not affect oxidative damage or lifespan in mice, but decreases expression of antioxidant protection genes.
Selman C; McLaren JS; Meyer C; Duncan JS; Redman P; Collins AR; Duthie GG; Speakman JR
Mech Ageing Dev; 2006 Dec; 127(12):897-904. PubMed ID: 17092545
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D deficiency and associated factors in hemodialysis patients.
Jean G; Charra B; Chazot C
J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
[TBL] [Abstract][Full Text] [Related]
26. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
Plummer M; Vivas J; Lopez G; Bravo JC; Peraza S; Carillo E; Cano E; Castro D; Andrade O; Sánchez V; Garcia R; Buiatti E; Aebischer C; Franceschi S; Oliver W; Muñoz N
J Natl Cancer Inst; 2007 Jan; 99(2):137-46. PubMed ID: 17227997
[TBL] [Abstract][Full Text] [Related]
27. Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation.
Stopper H; Treutlein AT; Bahner U; Schupp N; Schmid U; Brink A; Perna A; Heidland A
Nephrol Dial Transplant; 2008 Oct; 23(10):3272-9. PubMed ID: 18469307
[TBL] [Abstract][Full Text] [Related]
28. Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes.
Anderson RA; Evans LM; Ellis GR; Khan N; Morris K; Jackson SK; Rees A; Lewis MJ; Frenneaux MP
Diabet Med; 2006 Mar; 23(3):258-64. PubMed ID: 16492208
[TBL] [Abstract][Full Text] [Related]
29. Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia.
Shahrbanoo K; Taziki O
Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):933-6. PubMed ID: 18974579
[TBL] [Abstract][Full Text] [Related]
30. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.
Mantovani G; Macciò A; Madeddu C; Gramignano G; Serpe R; Massa E; Dessì M; Tanca FM; Sanna E; Deiana L; Panzone F; Contu P; Floris C
Nutrition; 2008 Apr; 24(4):305-13. PubMed ID: 18262758
[TBL] [Abstract][Full Text] [Related]
31. Vitamins and quality of life in hemodialysis patients.
Mydlik M; Derzsiová K
J Nephrol; 2008; 21 Suppl 13():S129-33. PubMed ID: 18446746
[TBL] [Abstract][Full Text] [Related]
32. Effects of vitamin C supplementation on antioxidants and lipid peroxidation markers in elderly subjects with type 2 diabetes.
Tessier DM; Khalil A; Trottier L; Fülöp T
Arch Gerontol Geriatr; 2009; 48(1):67-72. PubMed ID: 18077012
[TBL] [Abstract][Full Text] [Related]
33. Effect of oral vitamin E supplementation on oxidative stress in guinea-pigs with short-term hypothermia.
Aslan L; Meral I
Cell Biochem Funct; 2007; 25(6):711-5. PubMed ID: 17200985
[TBL] [Abstract][Full Text] [Related]
34. The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients.
Groenbaek K; Friis H; Hansen M; Ring-Larsen H; Krarup HB
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):985-9. PubMed ID: 16894312
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
Blair D; Byham-Gray L; Lewis E; McCaffrey S
J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
[TBL] [Abstract][Full Text] [Related]
36. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
37. [Oral administration of iron with vitamin C in haemodialyzed patients].
Derzsiová K; Mydlík M; Boldizsár J; Hríbiková M; Petrovicová J
Vnitr Lek; 2001 Apr; 47(4):210-4. PubMed ID: 15635885
[TBL] [Abstract][Full Text] [Related]
38. Antioxidant therapy by oral vitamin E and vitamin E-coated dialyzer in CAPD and haemodialysis patients.
Mydlík M; Derzsiová K; Rácz O; Sipulová A; Lovásová E
Prague Med Rep; 2006; 107(3):354-64. PubMed ID: 17385408
[TBL] [Abstract][Full Text] [Related]
39. [Changes in anti-oxidative homeostasis in hemodialysis patients].
Schmidtmann S; Popov I; Precht K; von Baehr R
Z Urol Nephrol; 1989 Feb; 82(2):77-80. PubMed ID: 2728633
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients.
Saab G; Young DO; Gincherman Y; Giles K; Norwood K; Coyne DW
Nephron Clin Pract; 2007; 105(3):c132-8. PubMed ID: 17228173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
